|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of upper-inner quadrant of breast, female
ICD-10 (CM) Code and Descriptor
|
C50.219 |
Malignant neoplasm of upper-inner quadrant of unspecified female breast
Diagnosis Valid for Female Patient Only
|
C50219 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.33%
|
23.21%
|
10.27%
|
4.73%
|
3.72%
|
1.62%
|
1.43%
|
1.34%
|
1.24%
|
0.33%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.219*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
80053
|
COMPREHEN METABOLIC PANEL |
511
|
511
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
473
|
473
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
408
|
409
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
355
|
356
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
235
|
258
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
72
|
72
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
67
|
85
|
|
82306
|
VITAMIN D 25 HYDROXY |
65
|
65
|
|
J9395
|
INJECTION, FULVESTRANT |
63
|
1,260
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
62
|
62
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
49
|
49
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
48
|
2,175
|
|
82728
|
ASSAY OF FERRITIN |
47
|
47
|
|
85027
|
COMPLETE CBC AUTOMATED |
46
|
46
|
|
83735
|
ASSAY OF MAGNESIUM |
43
|
43
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
39
|
39
|
|
83540
|
ASSAY OF IRON |
38
|
38
|
|
77066
|
DX MAMMO INCL CAD BI |
35
|
35
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
34
|
34
|
|
82607
|
VITAMIN B-12 |
34
|
34
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.219 related to the following DRG Codes:
582-583
597-599
|
